| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.792 | 0.003 | 0.792 | Mcl-1 antagonist | |||
| 0.777 | 0.005 | 0.777 | Aldehyde oxidase inhibitor | 0.192 0.109 DBMET00488 0.413 0.045 DB11309 | ||
| 0.62 | 0.004 | 0.62 | Peroxidase inhibitor | 0.145 0.081 DBMET00488 0.532 0.007 DB11309 | ||
| 0.622 | 0.008 | 0.622 | 5 Hydroxytryptamine release inhibitor | 0.593 0.012 DBMET00488 0.355 0.111 DB11309 | ||
| 0.616 | 0.006 | 0.616 | GABA C receptor rho-3 antagonist | 0.497 0.027 DB11309 | ||
| 0.61 | 0.047 | 0.793 | Apoptosis agonist | 0.793 0.017 DBMET00488 | DBMET00488 | |
| 0.536 | 0.022 | 0.536 | 5 Hydroxytryptamine release stimulant | 0.529 0.023 DBMET00488 0.359 0.054 DB11309 | ||
| 0.535 | 0.048 | 0.819 | Caspase 9 stimulant | 0.819 0.009 DBMET00488 0.31 0.183 DB11309 | DBMET00488 | |
| 0.506 | 0.032 | 0.743 | Cholesterol antagonist | 0.743 0.005 DBMET00488 0.622 0.016 DB11309 | DBMET00488 | |
| 0.461 | 0.006 | 0.461 | 5 Hydroxytryptamine uptake stimulant | 0.216 0.123 DBMET00488 0.335 0.03 DB11309 | ||
| 0.452 | 0.004 | 0.452 | Cystathionine beta-synthase inhibitor | 0.257 0.014 DBMET00488 0.142 0.044 DB11309 | ||
| 0.444 | 0.005 | 0.444 | Tyrosine 3 hydroxylase inhibitor | 0.186 0.163 DBMET00488 0.325 0.023 DB11309 | ||
| 0.456 | 0.047 | 0.657 | Histamine release inhibitor | 0.657 0.006 DBMET00488 0.53 0.02 DB11309 | DBMET00488 | |
| 0.423 | 0.023 | 0.725 | Superoxide dismutase inhibitor | 0.725 0.004 DB11309 | DB11309 | |
| 0.45 | 0.05 | 0.45 | Calcium channel L-type activator | |||
| 0.414 | 0.018 | 0.414 | Pyruvate kinase inhibitor | 0.135 0.13 DBMET00488 0.136 0.129 DB11309 | ||
| 0.481 | 0.096 | 0.916 | Antiinflammatory | 0.916 0.005 DBMET00488 0.29 0.225 DB11309 | DBMET00488 | |
| 0.403 | 0.024 | 0.403 | Calcium channel activator | 0.249 0.149 DBMET00488 0.38 0.033 DB11309 | ||
| 0.399 | 0.039 | 0.399 | 12-Lipoxygenase inhibitor | |||
| 0.431 | 0.075 | 0.431 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.431 0.075 DB11309 | ||
| 0.354 | 0.005 | 0.354 | Nitric-oxide synthase stimulant | 0.312 0.009 DBMET00488 0.229 0.05 DB11309 | ||
| 0.405 | 0.062 | 0.728 | Transcription factor NF kappa B inhibitor | 0.728 0.018 DBMET00488 0.267 0.116 DB11309 | DBMET00488 | |
| 0.36 | 0.023 | 0.492 | RNA-directed DNA polymerase inhibitor | 0.477 0.012 DBMET00488 0.492 0.011 DB11309 | DB11309 | |
| 0.356 | 0.023 | 0.562 | Anesthetic general | 0.562 0.005 DBMET00488 | DBMET00488 | |
| 0.373 | 0.043 | 0.373 | Aryl hydrocarbon receptor agonist | |||
| 0.364 | 0.036 | 0.768 | Free radical scavenger | 0.768 0.004 DBMET00488 | DBMET00488 | |
| 0.338 | 0.011 | 0.338 | Neurotrophic factor enhancer | 0.315 0.014 DBMET00488 0.16 0.124 DB11309 | ||
| 0.331 | 0.004 | 0.331 | Purinergic P2 antagonist | |||
| 0.333 | 0.007 | 0.337 | Succinate dehydrogenase inhibitor | 0.22 0.035 DBMET00488 0.337 0.006 DB11309 | DB11309 | |
| 0.326 | 0.005 | 0.326 | ABCA1 expression enhancer | |||
| 0.335 | 0.014 | 0.713 | Amylase inhibitor | 0.713 0.003 DBMET00488 0.104 0.093 DB11309 | DBMET00488 | |
| 0.329 | 0.013 | 0.916 | Alpha-N-acetylglucosaminidase inhibitor | 0.916 0.001 DBMET00488 0.472 0.006 DB11309 | DBMET00488 | |
| 0.319 | 0.004 | 0.319 | Creatine kinase inhibitor | 0.129 0.035 DBMET00488 0.252 0.005 DB11309 | ||
| 0.386 | 0.081 | 0.39 | 15-Lipoxygenase inhibitor | 0.39 0.079 DB11309 | DB11309 | |
| 0.349 | 0.047 | 0.829 | Antioxidant | 0.829 0.004 DBMET00488 0.464 0.025 DB11309 | DBMET00488 | |
| 0.306 | 0.007 | 0.306 | Ferrochelatase inhibitor | 0.144 0.04 DBMET00488 0.279 0.009 DB11309 | ||
| 0.387 | 0.09 | 0.387 | Analgesic | |||
| 0.301 | 0.005 | 0.301 | Estrogen receptor beta antagonist | |||
| 0.314 | 0.019 | 0.314 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.303 0.023 DBMET00488 0.184 0.088 DB11309 | ||
| 0.401 | 0.114 | 0.665 | Alpha-glucosidase inhibitor | 0.665 0.04 DBMET00488 | DBMET00488 | |
| 0.336 | 0.054 | 0.336 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.285 | 0.007 | 0.285 | Estrogen antagonist | |||
| 0.301 | 0.029 | 0.301 | 5 Hydroxytryptamine 1E antagonist | 0.182 0.151 DB11309 | ||
| 0.298 | 0.029 | 0.478 | Non-steroidal antiinflammatory agent | 0.478 0.008 DBMET00488 0.175 0.091 DB11309 | DBMET00488 | |
| 0.327 | 0.059 | 0.327 | Lipoxygenase inhibitor | |||
| 0.277 | 0.017 | 0.277 | Cyclooxygenase 1 inhibitor | 0.181 0.043 DBMET00488 | ||
| 0.302 | 0.043 | 0.599 | DNA synthesis inhibitor | 0.599 0.007 DBMET00488 0.295 0.045 DB11309 | DBMET00488 | |
| 0.271 | 0.017 | 0.271 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.258 | 0.004 | 0.258 | Purinergic P2X antagonist | |||
| 0.263 | 0.012 | 0.594 | UDP-glucose 4-epimerase inhibitor | 0.594 0.001 DBMET00488 0.205 0.017 DB11309 | DBMET00488 | |
| 0.271 | 0.024 | 0.397 | Interferon gamma antagonist | 0.397 0.011 DBMET00488 0.142 0.089 DB11309 | DBMET00488 | |
| 0.267 | 0.021 | 0.267 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.261 | 0.016 | 0.391 | Aldehyde dehydrogenase inhibitor | 0.391 0.006 DBMET00488 0.1 0.098 DB11309 | DBMET00488 | |
| 0.253 | 0.011 | 0.413 | Mannose-6-phosphate isomerase inhibitor | 0.413 0.003 DBMET00488 0.153 0.062 DB11309 | DBMET00488 | |
| 0.33 | 0.09 | 0.33 | Prostaglandin dehydrogenase inhibitor | |||
| 0.309 | 0.071 | 0.399 | Sodium/bile acid cotransporter inhibitor | 0.23 0.15 DBMET00488 0.399 0.017 DB11309 | DB11309 | |
| 0.247 | 0.012 | 0.247 | Carbonic anhydrase XV inhibitor | 0.196 0.019 DB11309 | ||
| 0.312 | 0.078 | 0.612 | Apoptosis antagonist | 0.612 0.009 DBMET00488 | DBMET00488 | |
| 0.241 | 0.008 | 0.355 | Porphobilinogen synthase inhibitor | 0.08 0.047 DBMET00488 0.355 0.004 DB11309 | DB11309 | |
| 0.254 | 0.025 | 0.254 | Heat shock protein 90 alpha antagonist | |||
| 0.315 | 0.087 | 0.315 | Thyroid hormone antagonist | |||
| 0.255 | 0.028 | 0.359 | Melanin inhibitor | 0.359 0.015 DBMET00488 0.126 0.121 DB11309 | DBMET00488 | |
| 0.233 | 0.006 | 0.233 | TRPA1 agonist | 0.1 0.088 DBMET00488 0.162 0.024 DB11309 | ||
| 0.24 | 0.016 | 0.322 | ATPase inhibitor | 0.322 0.005 DBMET00488 | DBMET00488 | |
| 0.233 | 0.011 | 0.464 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.464 0.003 DBMET00488 0.164 0.023 DB11309 | DBMET00488 | |
| 0.243 | 0.022 | 0.243 | NADPH oxidase inhibitor | 0.131 0.07 DBMET00488 | ||
| 0.235 | 0.015 | 0.365 | GABA C receptor agonist | 0.251 0.013 DBMET00488 0.365 0.006 DB11309 | DB11309 | |
| 0.286 | 0.067 | 0.286 | Insulysin inhibitor | 0.283 0.069 DB11309 | ||
| 0.299 | 0.079 | 0.299 | Streptokinase A inhibitor | |||
| 0.229 | 0.01 | 0.229 | Histidine decarboxylase inhibitor | 0.084 0.04 DBMET00488 0.085 0.039 DB11309 | ||
| 0.232 | 0.016 | 0.232 | GABA C receptor rho-2 antagonist | 0.191 0.034 DB11309 | ||
| 0.222 | 0.008 | 0.63 | HIV-1 integrase (3'-Processing) inhibitor | 0.084 0.032 DBMET00488 0.63 0.003 DB11309 | DB11309 | |
| 0.35 | 0.138 | 0.35 | DNA directed DNA polymerase inhibitor | |||
| 0.223 | 0.012 | 0.223 | CF transmembrane conductance regulator agonist | 0.195 0.025 DBMET00488 0.147 0.082 DB11309 | ||
| 0.236 | 0.025 | 0.236 | Heat shock protein 90 antagonist | |||
| 0.273 | 0.063 | 0.555 | Interleukin agonist | 0.555 0.006 DBMET00488 0.181 0.138 DB11309 | DBMET00488 | |
| 0.225 | 0.014 | 0.225 | Arachidonic acid antagonist | 0.205 0.029 DBMET00488 0.219 0.018 DB11309 | ||
| 0.231 | 0.024 | 0.231 | Alkaline phosphatase inhibitor | 0.155 0.057 DBMET00488 0.206 0.031 DB11309 | ||
| 0.22 | 0.013 | 0.22 | Carbonic anhydrase III inhibitor | 0.158 0.026 DBMET00488 0.219 0.013 DB11309 | ||
| 0.211 | 0.005 | 0.211 | DOPA decarboxylase inhibitor | 0.104 0.069 DBMET00488 0.141 0.026 DB11309 | ||
| 0.296 | 0.09 | 0.296 | Thyroid hormone beta antagonist | |||
| 0.255 | 0.052 | 0.255 | Neuropeptide Y2 antagonist | |||
| 0.212 | 0.01 | 0.691 | NADH dehydrogenase inhibitor | 0.691 0.001 DBMET00488 0.301 0.006 DB11309 | DBMET00488 | |
| 0.206 | 0.003 | 0.206 | Purinergic P2X7 antagonist | |||
| 0.232 | 0.029 | 0.462 | Phospholipase C inhibitor | 0.365 0.013 DBMET00488 0.462 0.007 DB11309 | DB11309 | |
| 0.223 | 0.022 | 0.274 | Cholesterol synthesis inhibitor | 0.178 0.033 DBMET00488 0.274 0.014 DB11309 | DB11309 | |
| 0.205 | 0.009 | 0.596 | HIV-1 integrase (Strand Transfer) inhibitor | 0.082 0.03 DBMET00488 0.596 0.003 DB11309 | DB11309 | |
| 0.291 | 0.095 | 0.509 | Vasodilator, coronary | 0.509 0.014 DBMET00488 0.256 0.128 DB11309 | DBMET00488 | |
| 0.2 | 0.006 | 0.2 | Alcohol oxidase inhibitor | 0.19 0.007 DBMET00488 0.143 0.011 DB11309 | ||
| 0.205 | 0.012 | 0.245 | Adenylate cyclase stimulant | 0.195 0.016 DBMET00488 0.245 0.004 DB11309 | DB11309 | |
| 0.338 | 0.145 | 0.338 | DNA polymerase beta inhibitor | |||
| 0.203 | 0.012 | 0.43 | Beta glucuronidase inhibitor | 0.43 0.004 DBMET00488 | DBMET00488 | |
| 0.203 | 0.012 | 0.312 | GABA C receptor antagonist | 0.1 0.078 DBMET00488 0.312 0.004 DB11309 | DB11309 | |
| 0.276 | 0.086 | 0.606 | Immunostimulant | 0.606 0.016 DBMET00488 0.369 0.059 DB11309 | DBMET00488 | |
| 0.202 | 0.013 | 0.202 | Androgen antagonist | |||
| 0.313 | 0.126 | 0.668 | Antibacterial | 0.668 0.011 DBMET00488 0.472 0.049 DB11309 | DBMET00488 | |
| 0.191 | 0.004 | 0.225 | Ca2+-transporting ATPase inhibitor | 0.225 0.002 DBMET00488 0.173 0.01 DB11309 | DBMET00488 | |
| 0.194 | 0.007 | 0.194 | Phenylalanine 4-hydroxylase inhibitor | 0.077 0.04 DBMET00488 0.192 0.007 DB11309 | ||
| 0.196 | 0.012 | 0.196 | HIV-1 integrase (Overall Integration) inhibitor | 0.182 0.016 DB11309 | ||
| 0.275 | 0.093 | 0.563 | Interleukin 2 agonist | 0.563 0.004 DBMET00488 | DBMET00488 | |
| 0.266 | 0.085 | 0.513 | Spasmolytic | 0.513 0.021 DBMET00488 0.275 0.081 DB11309 | DBMET00488 | |
| 0.196 | 0.016 | 0.196 | 5 Hydroxytryptamine 3A agonist | 0.113 0.062 DB11309 | ||
| 0.2 | 0.021 | 0.2 | Farnesoid X receptor antagonist | |||
| 0.183 | 0.005 | 0.183 | NMDA 2C receptor antagonist | 0.102 0.015 DB11309 | ||
| 0.294 | 0.118 | 0.294 | Calpain 2 inhibitor | |||
| 0.206 | 0.032 | 0.471 | Hexokinase inhibitor | 0.471 0.003 DBMET00488 0.163 0.064 DB11309 | DBMET00488 | |
| 0.189 | 0.016 | 0.189 | Interleukin 8 antagonist | 0.117 0.066 DB11309 | ||
| 0.2 | 0.03 | 0.414 | Cell wall synthesis inhibitor | 0.414 0.005 DBMET00488 0.351 0.008 DB11309 | DBMET00488 | |
| 0.208 | 0.039 | 0.46 | Protein kinase stimulant | 0.46 0.005 DBMET00488 | DBMET00488 | |
| 0.208 | 0.039 | 0.208 | Cyclooxygenase inhibitor | 0.136 0.082 DBMET00488 | ||
| 0.207 | 0.039 | 0.523 | Lipid peroxidase inhibitor | 0.523 0.005 DBMET00488 0.149 0.069 DB11309 | DBMET00488 | |
| 0.205 | 0.039 | 0.708 | NOS3 expression enhancer | 0.708 0.003 DBMET00488 | DBMET00488 | |
| 0.186 | 0.019 | 0.186 | Sphingosine 1-phosphate receptor 5 antagonist | 0.134 0.091 DB11309 | ||
| 0.189 | 0.023 | 0.57 | Cyclooxygenase 3 inhibitor | 0.57 0.003 DBMET00488 | DBMET00488 | |
| 0.193 | 0.027 | 0.193 | Toll-Like receptor 2 antagonist | 0.161 0.045 DBMET00488 | ||
| 0.273 | 0.111 | 0.433 | Vasodilator, peripheral | 0.433 0.046 DBMET00488 | DBMET00488 | |
| 0.247 | 0.086 | 0.247 | Transcription factor STAT3 inhibitor | 0.176 0.17 DBMET00488 | ||
| 0.174 | 0.014 | 0.637 | Triose-phosphate isomerase inhibitor | 0.637 0.002 DBMET00488 0.563 0.002 DB11309 | DBMET00488 | |
| 0.19 | 0.031 | 0.19 | MAO A inhibitor | |||
| 0.171 | 0.013 | 0.171 | NMDA 2 receptor antagonist | 0.171 0.013 DB11309 | ||
| 0.218 | 0.061 | 0.366 | DNA methyltransferase I inhibitor | 0.366 0.012 DBMET00488 0.136 0.122 DB11309 | DBMET00488 | |
| 0.171 | 0.017 | 0.182 | Carbonic anhydrase VI inhibitor | 0.112 0.033 DBMET00488 0.182 0.015 DB11309 | DB11309 | |
| 0.182 | 0.028 | 0.182 | 5-Lipoxygenase inhibitor | |||
| 0.158 | 0.005 | 0.158 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.093 0.012 DB11309 | ||
| 0.16 | 0.006 | 0.16 | Estrogen receptor beta agonist | 0.059 0.018 DB11309 | ||
| 0.172 | 0.02 | 0.172 | Sphingosine 1-phosphate receptor 2 antagonist | 0.155 0.035 DB11309 | ||
| 0.177 | 0.025 | 0.302 | Xanthine oxidase inhibitor | 0.302 0.007 DBMET00488 | DBMET00488 | |
| 0.194 | 0.042 | 0.194 | MAO inhibitor | |||
| 0.191 | 0.04 | 0.191 | Neurotensin receptor agonist | 0.175 0.056 DB11309 | ||
| 0.169 | 0.018 | 0.179 | Heat shock protein 70 antagonist | 0.179 0.012 DBMET00488 0.133 0.105 DB11309 | DBMET00488 | |
| 0.205 | 0.054 | 0.239 | 5 Hydroxytryptamine 3E antagonist | 0.239 0.022 DB11309 | DB11309 | |
| 0.163 | 0.012 | 0.177 | Anabolic | 0.128 0.032 DBMET00488 0.177 0.008 DB11309 | DB11309 | |
| 0.241 | 0.09 | 0.285 | Gastrin inhibitor | 0.258 0.07 DBMET00488 0.285 0.044 DB11309 | DB11309 | |
| 0.212 | 0.063 | 0.639 | Nitric oxide antagonist | 0.639 0.008 DBMET00488 | DBMET00488 | |
| 0.159 | 0.011 | 0.185 | Glutamate decarboxylase inhibitor | 0.097 0.032 DBMET00488 0.185 0.008 DB11309 | DB11309 | |
| 0.161 | 0.015 | 0.161 | Electrolyte absorption antagonist | 0.135 0.026 DB11309 | ||
| 0.24 | 0.094 | 0.24 | Transcription factor STAT inhibitor | |||
| 0.156 | 0.011 | 0.303 | Estrogen agonist | 0.058 0.031 DBMET00488 0.303 0.005 DB11309 | DB11309 | |
| 0.16 | 0.018 | 0.16 | Alcohol dehydrogenase inhibitor | 0.137 0.025 DBMET00488 0.118 0.036 DB11309 | ||
| 0.148 | 0.006 | 0.148 | D-Ala-D-Ala ligase inhibitor | 0.093 0.039 DB11309 | ||
| 0.164 | 0.023 | 0.164 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.162 | 0.021 | 0.162 | NMDA receptor antagonist | 0.133 0.03 DB11309 | ||
| 0.146 | 0.004 | 0.146 | Estrogen-related receptor beta agonist | 0.093 0.035 DB11309 | ||
| 0.157 | 0.017 | 0.157 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.095 0.04 DB11309 | ||
| 0.149 | 0.008 | 0.164 | GABA aminotransferase inhibitor | 0.164 0.006 DBMET00488 0.074 0.056 DB11309 | DBMET00488 | |
| 0.158 | 0.019 | 0.158 | Prolactin inhibitor | 0.117 0.04 DB11309 | ||
| 0.153 | 0.014 | 0.153 | Macrophage migration inhibitory factor inhibitor | |||
| 0.162 | 0.024 | 0.162 | Potassium channel (Ca-activated) activator | |||
| 0.141 | 0.005 | 0.141 | Liver X receptor agonist | |||
| 0.148 | 0.012 | 0.148 | Prostaglandin-E synthase inhibitor | |||
| 0.166 | 0.03 | 0.166 | Pregnane X receptor agonist | 0.165 0.032 DB11309 | ||
| 0.143 | 0.008 | 0.143 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.092 0.019 DBMET00488 | ||
| 0.184 | 0.05 | 0.184 | Death-associated protein kinase 2 inhibitor | |||
| 0.142 | 0.008 | 0.195 | Glycine receptor agonist | 0.195 0.004 DBMET00488 0.14 0.008 DB11309 | DBMET00488 | |
| 0.135 | 0.002 | 0.135 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.044 0.023 DBMET00488 0.079 0.004 DB11309 | ||
| 0.144 | 0.012 | 0.144 | Estrogen receptor alpha antagonist | |||
| 0.207 | 0.076 | 0.247 | Psychostimulant | 0.247 0.06 DBMET00488 | DBMET00488 | |
| 0.136 | 0.005 | 0.136 | GABA B receptor agonist | 0.111 0.01 DB11309 | ||
| 0.151 | 0.021 | 0.154 | GABA C receptor rho-1 antagonist | 0.093 0.073 DBMET00488 0.154 0.02 DB11309 | DB11309 | |
| 0.192 | 0.063 | 0.192 | Amyloid beta precursor protein antagonist | |||
| 0.131 | 0.003 | 0.131 | Dopamine D5 agonist | 0.057 0.013 DB11309 | ||
| 0.155 | 0.028 | 0.233 | Photosensitizer | 0.233 0.008 DBMET00488 0.163 0.024 DB11309 | DBMET00488 | |
| 0.133 | 0.006 | 0.133 | Estrogen receptor alpha agonist | |||
| 0.158 | 0.031 | 0.158 | Vanilloid 1 agonist | 0.144 0.045 DBMET00488 0.141 0.048 DB11309 | ||
| 0.148 | 0.024 | 0.148 | Urease inhibitor | 0.103 0.063 DB11309 | ||
| 0.132 | 0.008 | 0.132 | NMDA receptor subunit 3B antagonist | |||
| 0.197 | 0.074 | 0.197 | Histone acetyltransferase inhibitor | |||
| 0.131 | 0.01 | 0.131 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.209 | 0.088 | 0.513 | Peptidyltransferase inhibitor | 0.513 0.003 DBMET00488 | DBMET00488 | |
| 0.144 | 0.023 | 0.266 | Carbonic anhydrase XIII inhibitor | 0.156 0.02 DBMET00488 0.266 0.008 DB11309 | DB11309 | |
| 0.132 | 0.013 | 0.132 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.197 | 0.081 | 0.389 | DNA methylase inhibitor | 0.389 0.012 DBMET00488 | DBMET00488 | |
| 0.135 | 0.019 | 0.135 | Lanosterol 14 alpha demethylase inhibitor | 0.092 0.069 DB11309 | ||
| 0.205 | 0.09 | 0.408 | Cyclic AMP phosphodiesterase inhibitor | 0.408 0.015 DBMET00488 | DBMET00488 | |
| 0.125 | 0.01 | 0.145 | Purinergic P2X1 antagonist | 0.125 0.01 DBMET00488 0.145 0.008 DB11309 | DB11309 | |
| 0.161 | 0.046 | 0.161 | Cyclooxygenase 2 inhibitor | 0.103 0.101 DBMET00488 | ||
| 0.13 | 0.016 | 0.185 | Glutamate release inhibitor | 0.185 0.005 DBMET00488 0.093 0.055 DB11309 | DBMET00488 | |
| 0.127 | 0.013 | 0.164 | HIV-1 integrase inhibitor | 0.164 0.007 DB11309 | DB11309 | |
| 0.123 | 0.009 | 0.123 | Androgen agonist | 0.094 0.017 DB11309 | ||
| 0.157 | 0.044 | 0.302 | Monophenol monooxygenase inhibitor | 0.302 0.018 DBMET00488 0.155 0.045 DB11309 | DBMET00488 | |
| 0.278 | 0.168 | 0.278 | Transcription factor inhibitor | |||
| 0.129 | 0.019 | 0.129 | Keratolytic | 0.071 0.063 DBMET00488 0.074 0.058 DB11309 | ||
| 0.125 | 0.016 | 0.144 | Bile acid receptor antagonist | 0.103 0.044 DBMET00488 0.144 0.009 DB11309 | DB11309 | |
| 0.112 | 0.003 | 0.112 | Pregnane X receptor antagonist | 0.063 0.024 DB11309 | ||
| 0.139 | 0.031 | 0.31 | Adenylate kinase inhibitor | 0.31 0.006 DBMET00488 0.309 0.006 DB11309 | DBMET00488 | |
| 0.228 | 0.12 | 0.44 | Hypoxia-inducible factor 1 alpha inhibitor | 0.44 0.022 DBMET00488 0.22 0.129 DB11309 | DBMET00488 | |
| 0.112 | 0.004 | 0.112 | Dihydroorotate oxidase inhibitor | 0.081 0.01 DB11309 | ||
| 0.13 | 0.025 | 0.245 | Thioredoxin inhibitor | 0.245 0.005 DBMET00488 | DBMET00488 | |
| 0.189 | 0.085 | 0.19 | Insulin sensitizer | 0.19 0.084 DBMET00488 0.168 0.11 DB11309 | DBMET00488 | |
| 0.113 | 0.009 | 0.113 | Aryl hydrocarbon receptor antagonist | |||
| 0.232 | 0.129 | 0.399 | Caspase 3 stimulant | 0.399 0.045 DBMET00488 | DBMET00488 | |
| 0.144 | 0.04 | 0.28 | Aminopeptidase B inhibitor | 0.089 0.073 DBMET00488 0.28 0.01 DB11309 | DB11309 | |
| 0.114 | 0.012 | 0.114 | Bcl2 antagonist | |||
| 0.151 | 0.049 | 0.19 | Interleukin 4 antagonist | 0.19 0.025 DBMET00488 | DBMET00488 | |
| 0.109 | 0.008 | 0.109 | NMDA receptor subunit 3A antagonist | |||
| 0.115 | 0.015 | 0.218 | Biliverdin reductase inhibitor | 0.218 0.005 DBMET00488 0.128 0.012 DB11309 | DBMET00488 | |
| 0.142 | 0.042 | 0.244 | Microtubule formation inhibitor | 0.244 0.01 DBMET00488 0.111 0.073 DB11309 | DBMET00488 | |
| 0.156 | 0.056 | 0.156 | Neuropeptide Y1 antagonist | |||
| 0.139 | 0.039 | 0.258 | Mucolytic | 0.258 0.006 DBMET00488 0.156 0.029 DB11309 | DBMET00488 | |
| 0.107 | 0.008 | 0.107 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.117 | 0.02 | 0.204 | Glycine receptor antagonist | 0.204 0.003 DBMET00488 0.203 0.003 DB11309 | DBMET00488 | |
| 0.122 | 0.026 | 0.122 | CYP2A6 inhibitor | |||
| 0.12 | 0.025 | 0.514 | Phosphofructokinase-1 inhibitor | 0.514 0.002 DBMET00488 0.235 0.008 DB11309 | DBMET00488 | |
| 0.1 | 0.005 | 0.1 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.132 | 0.04 | 0.404 | AMP-activated protein kinase stimulant | 0.404 0.004 DBMET00488 | DBMET00488 | |
| 0.132 | 0.041 | 0.132 | Transcription factor STAT6 inhibitor | |||
| 0.104 | 0.013 | 0.104 | Alpha 2 adrenoreceptor agonist | |||
| 0.1 | 0.011 | 0.1 | Heat shock protein 90 beta antagonist | |||
| 0.1 | 0.01 | 0.1 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.14 | 0.054 | 0.171 | Cathepsin H inhibitor | 0.171 0.033 DB11309 | DB11309 | |
| 0.101 | 0.014 | 0.101 | 5 Hydroxytryptamine 2A agonist | |||
| 0.102 | 0.015 | 0.102 | NMDA receptor glycine site agonist | 0.088 0.023 DB11309 | ||
| 0.112 | 0.025 | 0.219 | Glutamate dehydrogenase inhibitor | 0.219 0.009 DBMET00488 0.212 0.009 DB11309 | DBMET00488 | |
| 0.098 | 0.011 | 0.098 | Glutamate (mGluR6) antagonist | 0.089 0.016 DBMET00488 0.086 0.019 DB11309 | ||
| 0.113 | 0.028 | 0.113 | Bromodomain-containing protein 2 inhibitor | 0.08 0.077 DB11309 | ||
| 0.156 | 0.071 | 0.156 | Cytidine deaminase inhibitor | |||
| 0.112 | 0.027 | 0.112 | Glutathione S-transferase inhibitor | |||
| 0.116 | 0.033 | 0.116 | Histamine N-methyltransferase inhibitor | 0.076 0.072 DB11309 | ||
| 0.088 | 0.005 | 0.088 | Adenylate cyclase 1 inhibitor | 0.046 0.032 DB11309 | ||
| 0.1 | 0.017 | 0.1 | Vanilloid 4 agonist | 0.091 0.024 DB11309 | ||
| 0.129 | 0.046 | 0.129 | MAO B inhibitor | |||
| 0.102 | 0.02 | 0.108 | CC chemokine 5 receptor agonist | 0.108 0.014 DB11309 | DB11309 | |
| 0.189 | 0.107 | 0.381 | Antiamyloidogenic | 0.381 0.032 DBMET00488 0.162 0.131 DB11309 | DBMET00488 | |
| 0.097 | 0.016 | 0.097 | MAP kinase kinase 7 inhibitor | 0.08 0.046 DB11309 | ||
| 0.197 | 0.117 | 0.197 | Calpain inhibitor | |||
| 0.096 | 0.017 | 0.324 | Carbonic anhydrase VB inhibitor | 0.324 0.003 DB11309 | DB11309 | |
| 0.164 | 0.085 | 0.8 | Dual specificity phosphatase 3 inhibitor | 0.8 0.002 DB11309 | DB11309 | |
| 0.099 | 0.02 | 0.22 | NMDA receptor agonist | 0.22 0.004 DB11309 | DB11309 | |
| 0.142 | 0.064 | 0.142 | Nav1.6 sodium channel blocker | |||
| 0.082 | 0.004 | 0.082 | ATP citrate lysase inhibitor | |||
| 0.226 | 0.148 | 0.773 | Antithrombotic | 0.773 0.005 DBMET00488 0.475 0.033 DB11309 | DBMET00488 | |
| 0.091 | 0.014 | 0.091 | Exportin-1 inhibitor | 0.082 0.022 DB11309 | ||
| 0.17 | 0.094 | 0.17 | Amyloid beta aggregation inhibitor | |||
| 0.097 | 0.021 | 0.241 | Carbamoyl phosphate synthetase inhibitor | 0.191 0.008 DBMET00488 0.241 0.006 DB11309 | DB11309 | |
| 0.134 | 0.058 | 0.181 | CC chemokine 6 receptor antagonist | 0.181 0.005 DBMET00488 | DBMET00488 | |
| 0.089 | 0.014 | 0.089 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.085 | 0.011 | 0.085 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.1 | 0.027 | 0.29 | Carbonic anhydrase V inhibitor | 0.29 0.004 DB11309 | DB11309 | |
| 0.131 | 0.059 | 0.131 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.108 | 0.036 | 0.309 | Catalase inhibitor | 0.098 0.039 DBMET00488 0.309 0.005 DB11309 | DB11309 | |
| 0.083 | 0.012 | 0.083 | Calcium channel P-type blocker | 0.061 0.055 DB11309 | ||
| 0.104 | 0.034 | 0.104 | Adrenaline agonist | |||
| 0.101 | 0.031 | 0.149 | Na+ K+ transporting ATPase inhibitor | 0.149 0.006 DBMET00488 0.129 0.012 DB11309 | DBMET00488 | |
| 0.13 | 0.06 | 0.268 | Adenylate cyclase inhibitor | 0.268 0.017 DBMET00488 0.104 0.081 DB11309 | DBMET00488 | |
| 0.112 | 0.043 | 0.112 | MAP kinase kinase 1 inhibitor | 0.085 0.079 DB11309 | ||
| 0.096 | 0.027 | 0.171 | Carbonic anhydrase VA inhibitor | 0.171 0.007 DB11309 | DB11309 | |
| 0.097 | 0.03 | 0.107 | Aminopeptidase I inhibitor | 0.079 0.043 DBMET00488 0.107 0.024 DB11309 | DB11309 | |
| 0.098 | 0.031 | 0.098 | Thioredoxin reductase inhibitor | |||
| 0.125 | 0.059 | 0.125 | Protein kinase (CK2) alpha inhibitor | |||
| 0.082 | 0.016 | 0.082 | Transcription factor RelA inhibitor | 0.064 0.042 DB11309 | ||
| 0.146 | 0.081 | 0.46 | Diuretic | 0.458 0.01 DBMET00488 0.46 0.009 DB11309 | DB11309 | |
| 0.072 | 0.008 | 0.072 | Liver X receptor alpha agonist | |||
| 0.097 | 0.034 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.153 | 0.091 | 0.818 | Dual specificity phosphatase inhibitor | 0.818 0.002 DB11309 | DB11309 | |
| 0.081 | 0.019 | 0.081 | MDM2 inhibitor | |||
| 0.155 | 0.093 | 0.155 | Catenin beta inhibitor | |||
| 0.074 | 0.012 | 0.296 | Adenine nucleotide translocase inhibitor | 0.18 0.003 DBMET00488 0.296 0.002 DB11309 | DB11309 | |
| 0.1 | 0.04 | 0.13 | ATPase (Vacuolar H+) inhibitor | 0.13 0.014 DBMET00488 | DBMET00488 | |
| 0.098 | 0.038 | 0.104 | Granulocyte macrophage colony stimulating factor agonist | 0.104 0.029 DB11309 | DB11309 | |
| 0.08 | 0.02 | 0.276 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.276 0.004 DBMET00488 0.103 0.014 DB11309 | DBMET00488 | |
| 0.115 | 0.055 | 0.53 | Expectorant | 0.53 0.003 DBMET00488 0.128 0.046 DB11309 | DBMET00488 | |
| 0.098 | 0.038 | 0.098 | Myeloperoxidase inhibitor | |||
| 0.125 | 0.065 | 0.248 | DNA polymerase I inhibitor | 0.248 0.017 DBMET00488 | DBMET00488 | |
| 0.083 | 0.024 | 0.083 | Glutamate (mGluR7) antagonist | 0.077 0.031 DB11309 | ||
| 0.124 | 0.064 | 0.439 | Alkylator | 0.439 0.006 DBMET00488 0.185 0.031 DB11309 | DBMET00488 | |
| 0.063 | 0.005 | 0.063 | Kynurenine 3 monooxygenase inhibitor | 0.05 0.006 DB11309 | ||
| 0.075 | 0.018 | 0.075 | Sphingosine kinase 2 inhibitor | |||
| 0.078 | 0.02 | 0.078 | Cannabinoid CB2 receptor antagonist | |||
| 0.07 | 0.013 | 0.332 | Glucose-6-phosphate isomerase inhibitor | 0.332 0.001 DBMET00488 0.122 0.003 DB11309 | DBMET00488 | |
| 0.066 | 0.01 | 0.066 | Dopamine beta hydroxylase inhibitor | 0.046 0.04 DB11309 | ||
| 0.07 | 0.014 | 0.07 | Squalene epoxidase inhibitor | 0.066 0.016 DBMET00488 0.047 0.04 DB11309 | ||
| 0.127 | 0.071 | 0.175 | Antibacterial (Helicobacter pylori) | 0.153 0.044 DBMET00488 0.175 0.03 DB11309 | DB11309 | |
| 0.064 | 0.009 | 0.064 | Alpha 1d adrenoreceptor agonist | 0.045 0.02 DB11309 | ||
| 0.06 | 0.005 | 0.06 | Liver X receptor beta antagonist | |||
| 0.077 | 0.022 | 0.802 | NMDA 2B receptor antagonist | 0.802 0.002 DB11309 | DB11309 | |
| 0.094 | 0.041 | 0.094 | Vanilloid agonist | |||
| 0.103 | 0.049 | 0.103 | Interleukin 12 antagonist | 0.103 0.049 DBMET00488 | ||
| 0.075 | 0.022 | 0.075 | Fatty acid synthase inhibitor | |||
| 0.109 | 0.057 | 0.219 | Toll-Like receptor 4 antagonist | 0.219 0.005 DBMET00488 | DBMET00488 | |
| 0.102 | 0.05 | 0.285 | Uric acid excretion stimulant | 0.285 0.005 DBMET00488 | DBMET00488 | |
| 0.074 | 0.023 | 0.074 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.064 | 0.013 | 0.064 | Urate transporter 1 inhibitor | |||
| 0.082 | 0.031 | 0.082 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.056 | 0.005 | 0.056 | Estrogen-related receptor beta antagonist | |||
| 0.077 | 0.026 | 0.077 | Xanthine dehydrogenase inhibitor | |||
| 0.085 | 0.035 | 0.085 | Alpha adrenoreceptor agonist | |||
| 0.055 | 0.005 | 0.055 | CF transmembrane conductance regulator antagonist | 0.039 0.028 DB11309 | ||
| 0.055 | 0.005 | 0.127 | Sodium/glucose cotransporter 2 inhibitor | 0.127 0.002 DBMET00488 | DBMET00488 | |
| 0.072 | 0.023 | 0.072 | Botulinum neurotoxin type A inhibitor | |||
| 0.062 | 0.012 | 0.062 | Geranyltranstransferase inhibitor | 0.042 0.034 DB11309 | ||
| 0.069 | 0.02 | 0.236 | Phosphorylase inhibitor | 0.236 0.004 DBMET00488 0.067 0.022 DB11309 | DBMET00488 | |
| 0.097 | 0.048 | 0.122 | Ornithine decarboxylase inhibitor | 0.122 0.024 DBMET00488 | DBMET00488 | |
| 0.06 | 0.012 | 0.081 | Guanylate cyclase inhibitor | 0.081 0.003 DBMET00488 0.08 0.003 DB11309 | DBMET00488 | |
| 0.103 | 0.056 | 0.196 | Sphingomyelinase inhibitor | 0.196 0.01 DBMET00488 | DBMET00488 | |
| 0.062 | 0.015 | 0.062 | Dihydroorotase inhibitor | |||
| 0.051 | 0.004 | 0.051 | Thyroid hormone agonist | 0.037 0.007 DB11309 | ||
| 0.084 | 0.038 | 0.126 | Purinergic P2X2 antagonist | 0.126 0.019 DB11309 | DB11309 | |
| 0.075 | 0.029 | 0.075 | TRPA1 antagonist | |||
| 0.055 | 0.009 | 0.055 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.068 | 0.023 | 0.068 | Beta 2 adrenoreceptor agonist | 0.062 0.042 DB11309 | ||
| 0.064 | 0.019 | 0.064 | Topoisomerase II beta inhibitor | 0.061 0.021 DBMET00488 | ||
| 0.071 | 0.027 | 0.141 | Aldose reductase inhibitor | 0.141 0.011 DBMET00488 0.064 0.03 DB11309 | DBMET00488 | |
| 0.066 | 0.021 | 0.096 | Aconitate hydratase inhibitor | 0.075 0.016 DBMET00488 0.096 0.009 DB11309 | DB11309 | |
| 0.138 | 0.094 | 0.138 | Sigma receptor agonist | |||
| 0.082 | 0.038 | 0.082 | Cannabinoid receptor antagonist | |||
| 0.073 | 0.03 | 0.073 | Beta 3 adrenoreceptor antagonist | 0.064 0.046 DB11309 | ||
| 0.065 | 0.022 | 0.065 | 5 Hydroxytryptamine 2 agonist | |||
| 0.067 | 0.024 | 0.067 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.079 | 0.036 | 0.147 | Phospholipase D inhibitor | 0.068 0.058 DBMET00488 0.147 0.003 DB11309 | DB11309 | |
| 0.058 | 0.015 | 0.058 | Progesterone antagonist | |||
| 0.074 | 0.031 | 0.074 | Aromatase inhibitor | |||
| 0.054 | 0.011 | 0.054 | Potassium channel Kv1.1 blocker | |||
| 0.219 | 0.177 | 0.665 | Immunosuppressant | 0.665 0.006 DBMET00488 | DBMET00488 | |
| 0.071 | 0.029 | 0.192 | Argininosuccinate synthase inhibitor | 0.192 0.008 DBMET00488 0.096 0.02 DB11309 | DBMET00488 | |
| 0.172 | 0.13 | 0.172 | ErbB-1 antagonist | |||
| 0.073 | 0.032 | 0.073 | Cannabinoid CB1 receptor antagonist | |||
| 0.078 | 0.037 | 0.078 | Potassium channel large-conductance Ca-activated activator | |||
| 0.069 | 0.027 | 0.17 | Acyl-CoA dehydrogenase inhibitor | 0.17 0.007 DBMET00488 0.124 0.012 DB11309 | DBMET00488 | |
| 0.048 | 0.007 | 0.048 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.067 | 0.026 | 0.067 | NMDA 2A receptor antagonist | 0.057 0.031 DB11309 | ||
| 0.059 | 0.018 | 0.059 | Fructose-1,6-bisphosphatase inhibitor | 0.048 0.027 DB11309 | ||
| 0.043 | 0.004 | 0.043 | Estrogen-related receptor gamma antagonist | 0.029 0.017 DB11309 | ||
| 0.045 | 0.006 | 0.045 | Glutamate (mGluR3) agonist | 0.038 0.012 DBMET00488 0.033 0.02 DB11309 | ||
| 0.206 | 0.167 | 0.206 | Thioredoxin glutathione reductase inhibitor | |||
| 0.088 | 0.05 | 0.24 | Inducible nitric-oxide synthase inhibitor | 0.24 0.005 DB11309 | DB11309 | |
| 0.145 | 0.107 | 0.145 | Tumour necrosis factor antagonist | |||
| 0.051 | 0.013 | 0.11 | Phosphoglycerate kinase inhibitor | 0.046 0.016 DBMET00488 0.11 0.006 DB11309 | DB11309 | |
| 0.041 | 0.004 | 0.064 | Vanilloid 2 agonist | 0.064 0.002 DBMET00488 0.042 0.004 DB11309 | DBMET00488 | |
| 0.1 | 0.063 | 0.1 | Protein kinase (CK2) inhibitor | |||
| 0.133 | 0.096 | 0.198 | Phospholipase A2 inhibitor | 0.198 0.044 DBMET00488 0.187 0.05 DB11309 | DBMET00488 | |
| 0.061 | 0.024 | 0.118 | Carbonic anhydrase XIV inhibitor | 0.118 0.007 DBMET00488 0.046 0.037 DB11309 | DBMET00488 | |
| 0.048 | 0.011 | 0.048 | Liver X receptor beta agonist | |||
| 0.091 | 0.055 | 0.091 | Opioid antagonist | |||
| 0.064 | 0.028 | 0.064 | Alpha tubulin antagonist | |||
| 0.066 | 0.03 | 0.066 | Sphingosine 1-phosphate receptor 3 antagonist | 0.054 0.047 DB11309 | ||
| 0.094 | 0.058 | 0.185 | Protein kinase C zeta inhibitor | 0.185 0.013 DB11309 | DB11309 | |
| 0.088 | 0.052 | 0.088 | mTOR complex 2 inhibitor | 0.079 0.071 DB11309 | ||
| 0.107 | 0.071 | 0.211 | Acetylcholine release stimulant | 0.143 0.022 DBMET00488 0.211 0.004 DB11309 | DB11309 | |
| 0.046 | 0.01 | 0.046 | Lysophosphatidic acid 2 receptor antagonist | 0.04 0.012 DB11309 | ||
| 0.046 | 0.01 | 0.046 | Catechol O-methyltransferase inhibitor | |||
| 0.057 | 0.022 | 0.057 | Aldosterone antagonist | |||
| 0.048 | 0.013 | 0.053 | Glutamate (mGluR8) agonist | 0.044 0.017 DBMET00488 0.053 0.01 DB11309 | DB11309 | |
| 0.042 | 0.007 | 0.042 | CXC chemokine 2 receptor antagonist | |||
| 0.054 | 0.019 | 0.054 | Purinergic P2X4 antagonist | 0.047 0.029 DB11309 | ||
| 0.085 | 0.051 | 0.085 | Opioid kappa receptor antagonist | |||
| 0.041 | 0.007 | 0.125 | Sodium/glucose cotransporter inhibitor | 0.125 0.002 DBMET00488 | DBMET00488 | |
| 0.052 | 0.018 | 0.062 | Thymidine kinase inhibitor | 0.062 0.013 DBMET00488 0.059 0.014 DB11309 | DBMET00488 | |
| 0.098 | 0.064 | 0.098 | Glutamate (mGluR7) agonist | 0.093 0.075 DB11309 | ||
| 0.069 | 0.036 | 0.069 | 5 Hydroxytryptamine 3 agonist | |||
| 0.14 | 0.107 | 0.14 | Antipruritic | |||
| 0.043 | 0.01 | 0.098 | Uridine phosphorylase inhibitor | 0.098 0.002 DBMET00488 0.05 0.008 DB11309 | DBMET00488 | |
| 0.048 | 0.016 | 0.048 | Heme oxygenase inhibitor | |||
| 0.061 | 0.029 | 0.061 | 5 Hydroxytryptamine 7 agonist | |||
| 0.048 | 0.016 | 0.052 | Kainate receptor agonist | 0.051 0.013 DBMET00488 0.052 0.012 DB11309 | DB11309 | |
| 0.133 | 0.101 | 0.133 | MAP kinase 3 inhibitor | |||
| 0.064 | 0.032 | 0.09 | Sphingosine kinase inhibitor | 0.09 0.011 DB11309 | DB11309 | |
| 0.06 | 0.029 | 0.06 | Leukotriene C antagonist | |||
| 0.039 | 0.009 | 0.039 | NMDA receptor glycine site antagonist | |||
| 0.062 | 0.032 | 0.062 | Ryanodine receptor antagonist | 0.059 0.039 DB11309 | ||
| 0.056 | 0.025 | 0.063 | Potassium channel (Inward rectifier) activator | 0.063 0.017 DB11309 | DB11309 | |
| 0.039 | 0.009 | 0.039 | Prostaglandin EP2 agonist | |||
| 0.059 | 0.029 | 0.059 | Epithelial sodium channel blocker | 0.052 0.043 DBMET00488 0.056 0.034 DB11309 | ||
| 0.045 | 0.016 | 0.045 | Glutamate (mGluR3) antagonist | |||
| 0.076 | 0.047 | 0.746 | CDC25A inhibitor | 0.066 0.063 DBMET00488 0.746 0.001 DB11309 | DB11309 | |
| 0.15 | 0.121 | 0.15 | MAP kinase kinase 2 inhibitor | |||
| 0.051 | 0.023 | 0.051 | Oxytocin agonist | 0.051 0.023 DB11309 | ||
| 0.075 | 0.047 | 0.106 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.06 DBMET00488 0.106 0.01 DB11309 | DB11309 | |
| 0.038 | 0.01 | 0.038 | Liver X receptor alpha antagonist | |||
| 0.044 | 0.016 | 0.116 | Fumarate hydratase inhibitor | 0.116 0.005 DBMET00488 0.054 0.012 DB11309 | DBMET00488 | |
| 0.053 | 0.025 | 0.06 | Potassium channel (ATP-sensitive) activator | 0.06 0.016 DB11309 | DB11309 | |
| 0.048 | 0.02 | 0.048 | Nerve growth factor antagonist | |||
| 0.081 | 0.053 | 0.266 | Topoisomerase II alpha inhibitor | 0.266 0.009 DBMET00488 | DBMET00488 | |
| 0.056 | 0.028 | 0.056 | CXC chemokine 1 receptor antagonist | |||
| 0.114 | 0.086 | 0.272 | DNA repair enzyme inhibitor | 0.272 0.005 DBMET00488 0.127 0.06 DB11309 | DBMET00488 | |
| 0.034 | 0.007 | 0.042 | Dopamine D1 agonist | 0.024 0.014 DBMET00488 0.042 0.005 DB11309 | DB11309 | |
| 0.045 | 0.018 | 0.045 | 5 Hydroxytryptamine 2B agonist | |||
| 0.034 | 0.007 | 0.034 | Hedgehog signaling activator | 0.028 0.017 DB11309 | ||
| 0.108 | 0.08 | 0.226 | Beta amyloid protein antagonist | 0.226 0.011 DBMET00488 0.164 0.031 DB11309 | DBMET00488 | |
| 0.075 | 0.048 | 0.181 | Cathepsin G inhibitor | 0.181 0.017 DB11309 | DB11309 | |
| 0.034 | 0.007 | 0.206 | Glutamate (mGluR1a) agonist | 0.206 0.002 DB11309 | DB11309 | |
| 0.044 | 0.018 | 0.044 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.043 | 0.017 | 0.043 | Vanilloid 3 antagonist | |||
| 0.03 | 0.005 | 0.03 | Alpha 2a adrenoreceptor agonist | |||
| 0.127 | 0.101 | 0.528 | Hemostatic | 0.528 0.004 DBMET00488 0.343 0.012 DB11309 | DBMET00488 | |
| 0.103 | 0.08 | 0.103 | Anesthetic local | |||
| 0.063 | 0.039 | 0.063 | Heme oxygenase stimulant | |||
| 0.028 | 0.005 | 0.028 | Alpha 2b adrenoreceptor agonist | |||
| 0.038 | 0.015 | 0.038 | Liver X receptor antagonist | |||
| 0.057 | 0.034 | 0.074 | Glucosylceramidase inhibitor | 0.074 0.019 DBMET00488 | DBMET00488 | |
| 0.054 | 0.031 | 0.139 | Glucose-6-phosphate translocase inhibitor | 0.139 0.004 DBMET00488 | DBMET00488 | |
| 0.047 | 0.024 | 0.047 | Cathepsin L2 inhibitor | |||
| 0.075 | 0.054 | 0.075 | Analgesic, opioid | |||
| 0.065 | 0.044 | 0.065 | Dopamine D1 antagonist | |||
| 0.108 | 0.087 | 0.108 | MAP kinase kinase inhibitor | |||
| 0.024 | 0.003 | 0.024 | Progesterone receptor A antagonist | |||
| 0.099 | 0.079 | 0.099 | Protein kinase C gamma inhibitor | 0.099 0.079 DBMET00488 | ||
| 0.065 | 0.046 | 0.065 | Beta adrenoreceptor antagonist | |||
| 0.066 | 0.047 | 0.066 | Dopamine agonist | |||
| 0.054 | 0.035 | 0.403 | Alpha-mannosidase inhibitor | 0.403 0.001 DBMET00488 0.225 0.003 DB11309 | DBMET00488 | |
| 0.035 | 0.016 | 0.035 | Prostaglandin agonist | |||
| 0.024 | 0.006 | 0.024 | Estrogen-related receptor gamma agonist | |||
| 0.024 | 0.005 | 0.024 | Nicotinic acid receptor 1 antagonist | |||
| 0.037 | 0.019 | 0.037 | Free fatty acid receptor 1 antagonist | |||
| 0.066 | 0.048 | 0.066 | Potassium channel (ATP-sensitive) blocker | |||
| 0.039 | 0.021 | 0.039 | Nicotinic acid receptor agonist | |||
| 0.032 | 0.014 | 0.037 | Purinergic P2Y15 antagonist | 0.037 0.009 DBMET00488 0.037 0.009 DB11309 | DB11309 | |
| 0.06 | 0.042 | 0.06 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.025 | 0.007 | 0.025 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.102 | 0.085 | 0.449 | Topoisomerase II inhibitor | 0.449 0.008 DBMET00488 | DBMET00488 | |
| 0.047 | 0.031 | 0.047 | Carbonic anhydrase VII inhibitor | |||
| 0.057 | 0.041 | 0.057 | Dopamine uptake inhibitor | |||
| 0.041 | 0.025 | 0.061 | Dihydropteroate synthase inhibitor | 0.061 0.011 DB11309 | DB11309 | |
| 0.085 | 0.068 | 0.085 | Potassium channel activator | |||
| 0.045 | 0.029 | 0.045 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.044 | 0.027 | 0.044 | Alpha 1L adrenoreceptor agonist | |||
| 0.093 | 0.077 | 0.093 | Falcipain 3 inhibitor | |||
| 0.029 | 0.013 | 0.029 | Thymidine phosphorylase inhibitor | 0.025 0.02 DBMET00488 | ||
| 0.149 | 0.133 | 0.149 | Focal adhesion kinase 2 inhibitor | |||
| 0.09 | 0.075 | 0.139 | Phosphodiesterase 6D inhibitor | 0.139 0.013 DBMET00488 0.13 0.018 DB11309 | DBMET00488 | |
| 0.035 | 0.02 | 0.035 | Estrogen-related receptor alpha antagonist | |||
| 0.106 | 0.091 | 0.106 | Nav1.3 sodium channel blocker | |||
| 0.052 | 0.037 | 0.052 | Vanilloid 2 antagonist | |||
| 0.029 | 0.015 | 0.029 | Nicotinic acid receptor 2 antagonist | |||
| 0.05 | 0.036 | 0.05 | Thromboxane A2 antagonist | |||
| 0.052 | 0.039 | 0.052 | Thromboxane antagonist | |||
| 0.036 | 0.023 | 0.036 | Retinoid X alpha receptor agonist | |||
| 0.165 | 0.151 | 0.418 | DNA damaging | 0.418 0.025 DBMET00488 | DBMET00488 | |
| 0.026 | 0.013 | 0.026 | Prostaglandin E2 agonist | |||
| 0.035 | 0.022 | 0.036 | Adenosine uptake inhibitor | 0.036 0.021 DB11309 | DB11309 | |
| 0.032 | 0.019 | 0.032 | Cyclophilin A inhibitor | |||
| 0.054 | 0.041 | 0.054 | Immunoglobulin Fc receptor antagonist | 0.054 0.042 DB11309 | ||
| 0.017 | 0.005 | 0.017 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.009 DB11309 | ||
| 0.099 | 0.087 | 0.123 | Nav1.5 sodium channel blocker | 0.123 0.051 DB11309 | DB11309 | |
| 0.055 | 0.043 | 0.055 | Beta tubulin antagonist | |||
| 0.039 | 0.027 | 0.039 | GABA uptake inhibitor | 0.038 0.03 DB11309 | ||
| 0.034 | 0.022 | 0.034 | Protein kinase (CK2) beta inhibitor | |||
| 0.039 | 0.027 | 0.039 | Leukotriene C4 antagonist | |||
| 0.091 | 0.08 | 0.164 | Mediator release inhibitor | 0.164 0.023 DBMET00488 | DBMET00488 | |
| 0.02 | 0.008 | 0.046 | Telomerase stimulant | 0.046 0.001 DBMET00488 0.02 0.007 DB11309 | DBMET00488 | |
| 0.054 | 0.042 | 0.054 | Beta 1 adrenoreceptor antagonist | |||
| 0.024 | 0.013 | 0.024 | ICAM 1 antagonist | |||
| 0.049 | 0.038 | 0.049 | Beta 2 adrenoreceptor antagonist | |||
| 0.024 | 0.013 | 0.024 | Prostaglandin F2 alpha agonist | 0.023 0.015 DBMET00488 | ||
| 0.062 | 0.052 | 0.062 | Opioid mu receptor antagonist | |||
| 0.02 | 0.01 | 0.05 | Antibiotic Anthracycline-like | 0.05 0.002 DBMET00488 0.018 0.016 DB11309 | DBMET00488 | |
| 0.014 | 0.004 | 0.014 | Thyroid hormone beta agonist | |||
| 0.027 | 0.017 | 0.031 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 DBMET00488 0.031 0.01 DB11309 | DB11309 | |
| 0.035 | 0.026 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.024 DB11309 | DB11309 | |
| 0.042 | 0.032 | 0.042 | GABA B receptor antagonist | 0.042 0.031 DB11309 | ||
| 0.012 | 0.003 | 0.012 | DNA topoisomerase III inhibitor | |||
| 0.044 | 0.035 | 0.044 | Beta adrenoreceptor agonist | |||
| 0.1 | 0.091 | 0.1 | Caspase 3 inhibitor | |||
| 0.036 | 0.028 | 0.07 | Farnesoid X receptor agonist | 0.07 0.007 DB11309 | DB11309 | |
| 0.017 | 0.009 | 0.017 | Thromboxane A2 agonist | 0.015 0.011 DB11309 | ||
| 0.066 | 0.057 | 0.076 | Protein kinase C beta inhibitor | 0.076 0.037 DBMET00488 | DBMET00488 | |
| 0.032 | 0.024 | 0.032 | Sirtuin 2 inhibitor | |||
| 0.017 | 0.01 | 0.017 | Thyroid hormone alpha agonist | |||
| 0.024 | 0.016 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.042 | 0.035 | 0.047 | Dihydrofolate reductase inhibitor | 0.047 0.023 DB11309 | DB11309 | |
| 0.033 | 0.026 | 0.033 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.024 | 0.018 | 0.155 | Glutamate (mGluR1) agonist | 0.155 0.003 DB11309 | DB11309 | |
| 0.062 | 0.056 | 0.062 | HIV-1 reverse transcriptase inhibitor | |||
| 0.134 | 0.128 | 0.768 | Hepatoprotectant | 0.768 0.003 DBMET00488 0.321 0.024 DB11309 | DBMET00488 | |
| 0.034 | 0.028 | 0.055 | Ceramide glucosyltransferase inhibitor | 0.047 0.009 DBMET00488 0.055 0.005 DB11309 | DB11309 | |
| 0.015 | 0.01 | 0.015 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | |||
| 0.029 | 0.023 | 0.029 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.155 | 0.15 | 0.481 | Vasodilator | 0.481 0.013 DBMET00488 | DBMET00488 | |
| 0.02 | 0.015 | 0.02 | Retinoid X beta receptor antagonist | |||
| 0.032 | 0.027 | 0.032 | RNA-directed RNA polymerase inhibitor | |||
| 0.093 | 0.088 | 0.111 | Chelator | 0.111 0.063 DBMET00488 | DBMET00488 | |
| 0.037 | 0.033 | 0.037 | AMPA 4 receptor antagonist | |||
| 0.046 | 0.041 | 0.136 | Carbonic anhydrase XII inhibitor | 0.136 0.014 DBMET00488 0.046 0.041 DB11309 | DBMET00488 | |
| 0.029 | 0.025 | 0.029 | HCV NS5B polymerase inhibitor | |||
| 0.039 | 0.036 | 0.046 | Glutamate (mGluR group III) agonist | 0.046 0.026 DB11309 | DB11309 | |
| 0.034 | 0.03 | 0.034 | Nicotinic receptor beta4 subunit antagonist | |||
| 0.012 | 0.009 | 0.02 | Glutamate (mGluR6) agonist | 0.011 0.01 DBMET00488 0.02 0.004 DB11309 | DB11309 | |
| 0.022 | 0.018 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.028 0.007 DBMET00488 0.022 0.017 DB11309 | DBMET00488 | |
| 0.042 | 0.039 | 0.042 | Potassium channel Kv1.3 blocker | |||
| 0.037 | 0.034 | 0.037 | CDK5/p25 inhibitor | |||
| 0.036 | 0.033 | 0.036 | Kainate receptor antagonist | |||
| 0.01 | 0.008 | 0.01 | Thromboxane agonist | |||
| 0.055 | 0.052 | 0.055 | Cyclin D1 inhibitor | |||
| 0.068 | 0.066 | 0.389 | Antineoplastic antibiotic | 0.389 0.005 DBMET00488 | DBMET00488 | |
| 0.014 | 0.012 | 0.014 | Egl nine homolog 1 inhibitor | |||
| 0.028 | 0.026 | 0.028 | Prostaglandin D2 agonist | |||
| 0.028 | 0.027 | 0.04 | Cholesterol ester transfer protein antagonist | 0.04 0.013 DB11309 | DB11309 | |
| 0.105 | 0.104 | 0.16 | Nav1.2 sodium channel blocker | 0.16 0.051 DB11309 | DB11309 | |
| 0.041 | 0.04 | 0.041 | Thymidylate synthase inhibitor | |||
| 0.133 | 0.132 | 0.133 | Interleukin antagonist | |||
| 0.014 | 0.013 | 0.014 | NMDA receptor phencyclidine site antagonist | |||
| 0.046 | 0.046 | 0.103 | Carbonic anhydrase IX inhibitor | 0.103 0.019 DBMET00488 0.047 0.045 DB11309 | DBMET00488 | |
| 0.057 | 0.056 | 0.057 | CDC25B inhibitor | |||
| 0.031 | 0.03 | 0.034 | Glutamate (mGluR4) agonist | 0.034 0.023 DB11309 | DB11309 | |
| 0.046 | 0.046 | 0.048 | CD45 antagonist | 0.048 0.039 DB11309 | DB11309 | |
| 0.053 | 0.053 | 0.193 | Carbonic anhydrase inhibitor | 0.096 0.028 DBMET00488 0.193 0.01 DB11309 | DB11309 | |
| 0.023 | 0.024 | 0.028 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.028 0.019 DBMET00488 | DBMET00488 | |
| 0.04 | 0.04 | 0.422 | Mannosidase inhibitor | 0.422 0.001 DBMET00488 0.209 0.003 DB11309 | DBMET00488 | |
| 0.044 | 0.046 | 0.07 | Lysophosphatidic acid 3 receptor antagonist | 0.07 0.014 DB11309 | DB11309 | |
| 0.048 | 0.05 | 0.179 | Heparanase inhibitor | 0.179 0.002 DBMET00488 0.095 0.004 DB11309 | DBMET00488 | |
| 0.046 | 0.048 | 0.072 | Carbonic anhydrase II inhibitor | 0.072 0.029 DBMET00488 0.061 0.034 DB11309 | DBMET00488 | |
| 0.023 | 0.026 | 0.034 | Complement factor 1s inhibitor | 0.034 0.005 DB11309 | DB11309 | |
| 0.132 | 0.135 | 0.896 | Angiogenesis stimulant | 0.879 0.003 DBMET00488 0.896 0.002 DB11309 | DB11309 | |
| 0.013 | 0.017 | 0.028 | Purinergic P2Y1 agonist | 0.016 0.01 DBMET00488 0.028 0.004 DB11309 | DB11309 | |
| 0.043 | 0.048 | 0.049 | Bombesin 2 receptor antagonist | 0.049 0.034 DB11309 | DB11309 | |
| 0.03 | 0.035 | 0.032 | Tubulin agonist | 0.032 0.031 DBMET00488 | DBMET00488 | |
| 0.043 | 0.05 | 0.079 | Carbonic anhydrase I inhibitor | 0.069 0.029 DBMET00488 0.079 0.025 DB11309 | DB11309 | |
| 0.016 | 0.024 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 DBMET00488 0.02 0.008 DB11309 | DBMET00488 | |
| 0.024 | 0.033 | 0.029 | 5 Hydroxytryptamine 6 agonist | 0.029 0.02 DB11309 | DB11309 | |
| 0.056 | 0.065 | 0.125 | Interferon inducer | 0.112 0.009 DBMET00488 0.125 0.007 DB11309 | DB11309 | |
| 0.04 | 0.051 | 0.12 | Ornithine carbamoyltransferase inhibitor | 0.109 0.014 DBMET00488 0.12 0.013 DB11309 | DB11309 | |
| 0.025 | 0.037 | 0.1 | Arginase inhibitor | 0.1 0.004 DBMET00488 0.032 0.029 DB11309 | DBMET00488 | |
| 0.016 | 0.029 | 0.025 | Prostaglandin H2 antagonist | 0.025 0.018 DB11309 | DB11309 | |
| 0.017 | 0.029 | 0.025 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 DBMET00488 | DBMET00488 | |
| 0.035 | 0.047 | 0.098 | Adenosine deaminase inhibitor | 0.098 0.006 DBMET00488 0.076 0.01 DB11309 | DBMET00488 | |
| 0.156 | 0.169 | 0.758 | Hypoglycemic | 0.758 0.004 DBMET00488 | DBMET00488 | |
| 0.037 | 0.051 | 0.08 | Glutamate (mGluR5) agonist | 0.08 0.011 DB11309 | DB11309 | |
| 0.054 | 0.067 | 0.101 | Protease 3C (Human rhinovirus) inhibitor | 0.101 0.015 DB11309 | DB11309 | |
| 0.079 | 0.093 | 0.094 | Interleukin 1 beta converting enzyme inhibitor | 0.094 0.065 DBMET00488 | DBMET00488 | |
| 0.012 | 0.027 | 0.017 | Vitamin D receptor agonist | 0.017 0.011 DBMET00488 | DBMET00488 | |
| 0.047 | 0.061 | 0.056 | Carbonic anhydrase stimulant | 0.056 0.046 DB11309 | DB11309 | |
| 0.007 | 0.021 | 0.021 | Purinergic P2Y2 agonist | 0.021 0.002 DBMET00488 0.012 0.006 DB11309 | DBMET00488 | |
| 0.008 | 0.023 | 0.015 | Lysophosphatidic acid receptor 3 agonist | 0.015 0.008 DB11309 | DB11309 | |
| 0.051 | 0.066 | 0.058 | Leukotriene antagonist | 0.058 0.053 DBMET00488 | DBMET00488 | |
| 0.035 | 0.051 | 0.064 | AICAR transformylase inhibitor | 0.041 0.037 DBMET00488 0.064 0.012 DB11309 | DB11309 | |
| 0.03 | 0.049 | 0.052 | Membrane dipeptidase inhibitor | 0.052 0.014 DB11309 | DB11309 | |
| 0 | 0.02 | 0.004 | Purinergic P2Y6 agonist | 0.004 0.002 DBMET00488 | DBMET00488 | |
| 0.064 | 0.084 | 0.155 | Interferon agonist | 0.141 0.012 DBMET00488 0.155 0.01 DB11309 | DB11309 | |
| 0.042 | 0.064 | 0.069 | Leukotriene B4 antagonist | 0.069 0.02 DBMET00488 0.056 0.034 DB11309 | DBMET00488 | |
| 0.078 | 0.1 | 0.19 | Nitric-oxide synthase inhibitor | 0.19 0.011 DB11309 | DB11309 | |
| 0.018 | 0.04 | 0.026 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.015 DB11309 | DB11309 | |
| 0.036 | 0.06 | 0.043 | CC chemokine 4 receptor antagonist | 0.043 0.041 DB11309 | DB11309 | |
| 0.033 | 0.057 | 0.081 | Glutamate (mGluR group I) agonist | 0.081 0.012 DB11309 | DB11309 | |
| 0.007 | 0.034 | 0.021 | Carbonic anhydrase XI inhibitor | 0.021 0.004 DB11309 | DB11309 | |
| 0.009 | 0.036 | 0.027 | Carbonic anhydrase X inhibitor | 0.027 0.005 DB11309 | DB11309 | |
| 0.009 | 0.036 | 0.027 | Carbonic anhydrase VIII inhibitor | 0.027 0.005 DB11309 | DB11309 | |
| 0.105 | 0.135 | 0.757 | Protein-tyrosine phosphatase inhibitor | 0.191 0.05 DBMET00488 0.757 0.003 DB11309 | DB11309 | |
| 0.048 | 0.079 | 0.098 | Lipocortins synthesis agonist | 0.098 0.006 DBMET00488 0.054 0.051 DB11309 | DBMET00488 | |
| 0.009 | 0.04 | 0.016 | Adenosine A2 receptor agonist | 0.016 0.011 DBMET00488 | DBMET00488 | |
| 0.008 | 0.039 | 0.075 | Ileal bile acid transport inhibitor | 0.075 0.003 DBMET00488 0.018 0.011 DB11309 | DBMET00488 | |
| 0.008 | 0.039 | 0.018 | Aminopeptidase A inhibitor | 0.018 0.012 DB11309 | DB11309 | |
| 0.012 | 0.045 | 0.052 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.052 0.008 DBMET00488 0.036 0.014 DB11309 | DBMET00488 | |
| 0.067 | 0.106 | 0.406 | Topoisomerase I inhibitor | 0.406 0.005 DBMET00488 | DBMET00488 | |
| 0.079 | 0.118 | 0.242 | Nav1.4 sodium channel blocker | 0.242 0.01 DB11309 | DB11309 | |
| 0.016 | 0.057 | 0.022 | Vitamin D receptor antagonist | 0.022 0.016 DBMET00488 | DBMET00488 | |
| 0.023 | 0.065 | 0.044 | Carboxypeptidase B inhibitor | 0.044 0.01 DB11309 | DB11309 | |
| 0.022 | 0.067 | 0.073 | Toll-Like receptor 2 agonist | 0.073 0.017 DBMET00488 0.04 0.029 DB11309 | DBMET00488 | |
| 0.025 | 0.07 | 0.038 | Angiotensin AT1 receptor antagonist | 0.038 0.037 DB11309 | DB11309 | |
| 0.037 | 0.082 | 0.14 | Cytokine production stimulant | 0.14 0.003 DBMET00488 | DBMET00488 | |
| 0.135 | 0.18 | 0.58 | Tumour necrosis factor alpha release inhibitor | 0.58 0.008 DBMET00488 | DBMET00488 | |
| 0.115 | 0.161 | 0.401 | Interleukin 6 antagonist | 0.401 0.007 DBMET00488 | DBMET00488 | |
| 0.026 | 0.073 | 0.106 | Antimetabolite | 0.106 0.015 DBMET00488 | DBMET00488 | |
| 0.026 | 0.075 | 0.033 | Glutamate (mGluR8) antagonist | 0.033 0.032 DBMET00488 | DBMET00488 | |
| 0.056 | 0.106 | 0.072 | Phosphodiesterase VI inhibitor | 0.072 0.056 DB11309 | DB11309 | |
| 0.008 | 0.059 | 0.05 | Estrone sulfatase inhibitor | 0.05 0.007 DB11309 | DB11309 | |
| 0.017 | 0.069 | 0.075 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 DBMET00488 0.075 0.002 DB11309 | DB11309 | |
| 0.046 | 0.099 | 0.262 | Neuraminidase (influenza) inhibitor | 0.259 0.004 DBMET00488 0.262 0.004 DB11309 | DB11309 | |
| 0.053 | 0.106 | 0.073 | Adenosine A3 receptor antagonist | 0.073 0.054 DBMET00488 | DBMET00488 | |
| 0.021 | 0.075 | 0.127 | Dopamine D2 agonist | 0.127 0.008 DB11309 | DB11309 | |
| 0.026 | 0.08 | 0.119 | Leukocyte elastase inhibitor | 0.119 0.008 DB11309 | DB11309 | |
| 0.065 | 0.12 | 0.125 | Gastric antisecretory | 0.125 0.039 DB11309 | DB11309 | |
| 0.119 | 0.176 | 0.468 | Hypolipemic | 0.468 0.015 DBMET00488 | DBMET00488 | |
| 0.03 | 0.088 | 0.066 | Prostaglandin EP2 antagonist | 0.066 0.036 DBMET00488 | DBMET00488 | |
| 0.02 | 0.079 | 0.061 | Purinergic P2Y antagonist | 0.043 0.033 DBMET00488 0.061 0.019 DB11309 | DB11309 | |
| 0.024 | 0.085 | 0.04 | Histamine H2 receptor agonist | 0.04 0.034 DB11309 | DB11309 | |
| 0.033 | 0.094 | 0.566 | Selectin antagonist | 0.546 0.002 DBMET00488 0.566 0.002 DB11309 | DB11309 | |
| 0.01 | 0.072 | 0.032 | Corticosteroid-like | 0.032 0.006 DBMET00488 | DBMET00488 | |
| 0.029 | 0.091 | 0.041 | Histamine H1 receptor agonist | 0.041 0.036 DB11309 | DB11309 | |
| 0.04 | 0.105 | 0.066 | Transcription factor AP-1 inhibitor | 0.066 0.035 DBMET00488 | DBMET00488 | |
| 0.008 | 0.073 | 0.018 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.018 0.016 DBMET00488 | DBMET00488 | |
| 0.046 | 0.113 | 0.073 | Epoxide hydrolase inhibitor | 0.073 0.049 DB11309 | DB11309 | |
| 0.015 | 0.084 | 0.031 | Peptide deformylase inhibitor | 0.031 0.02 DB11309 | DB11309 | |
| 0.062 | 0.133 | 0.319 | Transcription factor NF kappa B stimulant | 0.319 0.004 DBMET00488 | DBMET00488 | |
| 0.023 | 0.098 | 0.034 | Protein kinase C beta I inhibitor | 0.034 0.022 DBMET00488 | DBMET00488 | |
| 0.022 | 0.105 | 0.045 | Metalloproteinase-3 inhibitor | 0.045 0.039 DB11309 | DB11309 | |
| 0.036 | 0.121 | 0.074 | Glutamate receptor agonist | 0.074 0.059 DB11309 | DB11309 | |
| 0.007 | 0.099 | 0.018 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.018 0.007 DBMET00488 | DBMET00488 | |
| 0.092 | 0.185 | 0.43 | Insulin secretagoues | 0.43 0.005 DBMET00488 | DBMET00488 | |
| 0.009 | 0.107 | 0.03 | Leukotriene B4 receptor 2 antagonist | 0.03 0.009 DBMET00488 | DBMET00488 | |
| 0.027 | 0.128 | 0.073 | Protein kinase C eta inhibitor | 0.073 0.027 DBMET00488 | DBMET00488 | |
| 0.029 | 0.131 | 0.312 | Factor IXa inhibitor | 0.131 0.005 DBMET00488 0.312 0.002 DB11309 | DB11309 | |
| 0.017 | 0.123 | 0.176 | Purinergic P2Y2 antagonist | 0.176 0.002 DB11309 | DB11309 | |
| 0.024 | 0.129 | 0.062 | Microtubule stabilization | 0.062 0.012 DBMET00488 | DBMET00488 | |
| 0.064 | 0.171 | 0.282 | Bone formation stimulant | 0.282 0.019 DBMET00488 | DBMET00488 | |
| 0.012 | 0.119 | 0.36 | NMDA 2D receptor antagonist | 0.36 0.001 DB11309 | DB11309 | |
| 0.033 | 0.142 | 0.06 | Factor III inhibitor | 0.06 0.017 DBMET00488 | DBMET00488 | |
| 0.008 | 0.117 | 0.055 | Purinergic P2X agonist | 0.055 0.008 DB11309 | DB11309 | |
| 0.022 | 0.139 | 0.221 | Neuraminidase inhibitor | 0.221 0.004 DBMET00488 0.172 0.005 DB11309 | DBMET00488 | |
| 0.011 | 0.129 | 0.09 | Protein 30S ribosomal subunit inhibitor | 0.09 0.004 DBMET00488 | DBMET00488 | |
| 0.002 | 0.124 | 0.023 | Antibiotic Macrolide-like | 0.023 0.006 DBMET00488 | DBMET00488 | |
| 0.036 | 0.165 | 0.299 | Histone deacetylase SIRT1 stimulant | 0.299 0.004 DBMET00488 | DBMET00488 | |
| 0.036 | 0.165 | 0.299 | Histone deacetylase stimulant | 0.299 0.004 DBMET00488 | DBMET00488 | |
| 0.049 | 0.181 | 0.113 | Breast cancer-resistant protein inhibitor | 0.113 0.045 DB11309 | DB11309 | |
| 0.1 | 0.233 | 0.174 | Lipocortins synthesis antagonist | 0.174 0.077 DBMET00488 | DBMET00488 | |
| 0.041 | 0.178 | 0.345 | Protein-tyrosine phosphatase 1B inhibitor | 0.184 0.034 DBMET00488 0.345 0.008 DB11309 | DB11309 | |
| 0.006 | 0.145 | 0.028 | Leukotriene B4 receptor 1 antagonist | 0.028 0.02 DBMET00488 | DBMET00488 | |
| 0.02 | 0.159 | 0.176 | Protein 50S ribosomal subunit inhibitor | 0.176 0.005 DBMET00488 | DBMET00488 | |
| 0.006 | 0.146 | 0.089 | Squalene synthetase inhibitor | 0.089 0.007 DBMET00488 0.07 0.01 DB11309 | DBMET00488 | |
| 0.056 | 0.2 | 0.351 | Multidrug resistance-associated protein 1 inhibitor | 0.146 0.027 DBMET00488 0.351 0.003 DB11309 | DB11309 | |
| 0.005 | 0.159 | 0.975 | Cholecystokinin A agonist | 0.975 0 DB11309 | DB11309 | |
| 0.042 | 0.197 | 0.077 | Chymotrypsin inhibitor | 0.077 0.058 DB11309 | DB11309 | |
| 0.01 | 0.166 | 0.064 | Factor Xa inhibitor | 0.064 0.022 DB11309 | DB11309 | |
| 0.004 | 0.165 | 0.026 | Sodium/hydrogen exchanger inhibitor | 0.026 0.005 DB11309 | DB11309 | |
| 0.002 | 0.167 | 0.018 | Purinergic P2Y agonist | 0.018 0.005 DBMET00488 | DBMET00488 | |
| 0.002 | 0.167 | 0.023 | Purinergic P2 agonist | 0.023 0.006 DBMET00488 0.015 0.01 DB11309 | DBMET00488 | |
| 0.002 | 0.167 | 0.023 | Purinergic receptor agonist | 0.023 0.006 DBMET00488 0.015 0.01 DB11309 | DBMET00488 | |
| 0.006 | 0.172 | 0.025 | Adenosine A1 receptor agonist | 0.025 0.016 DBMET00488 | DBMET00488 | |
| 0.018 | 0.187 | 0.119 | Antibiotic Aminoglycoside-like | 0.119 0.002 DBMET00488 | DBMET00488 | |
| 0.105 | 0.277 | 0.319 | Beta lactamase inhibitor | 0.319 0.127 DB11309 | DB11309 | |
| 0.005 | 0.192 | 0.988 | Cholecystokinin agonist | 0.988 0.001 DB11309 | DB11309 | |
| 0.074 | 0.273 | 0.154 | P-glycoprotein inhibitor | 0.154 0.111 DBMET00488 | DBMET00488 | |
| 0.072 | 0.271 | 0.508 | Platelet adhesion inhibitor | 0.502 0.005 DBMET00488 0.508 0.005 DB11309 | DB11309 | |
| 0.059 | 0.274 | 0.094 | Folate antagonist | 0.094 0.078 DBMET00488 | DBMET00488 | |
| 0.015 | 0.232 | 0.082 | Neuraminidase (Influenza A) inhibitor | 0.082 0.005 DBMET00488 | DBMET00488 | |
| 0.017 | 0.234 | 0.068 | H+/K+-transporting ATPase inhibitor | 0.068 0.019 DB11309 | DB11309 | |
| 0.042 | 0.271 | 0.505 | Thrombolytic | 0.505 0.005 DBMET00488 0.39 0.012 DB11309 | DBMET00488 | |
| 0.048 | 0.28 | 0.163 | Neurotrophic factor | 0.163 0.049 DBMET00488 | DBMET00488 | |
| 0.02 | 0.319 | 0.072 | Autotaxin inhibitor | 0.072 0.022 DB11309 | DB11309 | |
| 0.042 | 0.347 | 0.517 | Cell adhesion inhibitor | 0.517 0.004 DBMET00488 0.155 0.044 DB11309 | DBMET00488 | |
| 0.119 | 0.428 | 0.898 | Cyclophilin D inhibitor | 0.898 0.005 DBMET00488 | DBMET00488 | |
| 0.029 | 0.349 | 0.272 | Cell adhesion molecule inhibitor | 0.24 0.007 DBMET00488 0.272 0.005 DB11309 | DB11309 | |
| 0.008 | 0.332 | 0.068 | Follicle-stimulating hormone antagonist | 0.068 0.003 DB11309 | DB11309 | |
| 0.006 | 0.339 | 0.085 | Caspase 2 inhibitor | 0.085 0.005 DBMET00488 | DBMET00488 | |
| 0.005 | 0.34 | 0.022 | Motilin receptor agonist | 0.022 0.017 DBMET00488 | DBMET00488 | |
| 0.023 | 0.367 | 0.161 | DNA intercalator | 0.161 0.038 DBMET00488 | DBMET00488 | |
| 0.008 | 0.376 | 0.03 | Caspase 6 inhibitor | 0.03 0.023 DBMET00488 | DBMET00488 | |
| 0.012 | 0.381 | 0.992 | Cholecystokinin B agonist | 0.992 0 DB11309 | DB11309 | |
| 0.012 | 0.383 | 0.122 | Toll-Like receptor 4 agonist | 0.063 0.003 DBMET00488 0.122 0.002 DB11309 | DB11309 | |
| 0.064 | 0.474 | 0.315 | Antiobesity | 0.315 0.106 DBMET00488 | DBMET00488 | |
| 0.013 | 0.44 | 0.098 | Nitric oxide donor | 0.098 0.01 DBMET00488 | DBMET00488 | |
| 0.017 | 0.463 | 0.088 | Protease inhibitor | 0.088 0.077 DBMET00488 | DBMET00488 | |
| 0.012 | 0.462 | 0.074 | MAP kinase kinase 10 inhibitor | 0.074 0.034 DB11309 | DB11309 | |
| 0.009 | 0.46 | 0.16 | Elastase inhibitor | 0.16 0.004 DB11309 | DB11309 | |
| 0.044 | 0.521 | 0.823 | Angiogenesis inhibitor | 0.311 0.087 DBMET00488 0.823 0.005 DB11309 | DB11309 | |
| 0.056 | 0.544 | 0.767 | Immunomodulator | 0.767 0.005 DBMET00488 | DBMET00488 | |
| 0.012 | 0.519 | 0.151 | Thrombin inhibitor | 0.151 0.011 DB11309 | DB11309 | |
| 0.005 | 0.53 | 0.045 | Factor XIa inhibitor | 0.045 0.024 DB11309 | DB11309 | |
| 0.003 | 0.546 | 0.81 | Cholecystokinin A antagonist | 0.81 0.001 DB11309 | DB11309 | |
| 0.004 | 0.553 | 0.071 | Factor XI inhibitor | 0.071 0.005 DB11309 | DB11309 | |
| 0.003 | 0.575 | 0.026 | Follicle-stimulating hormone agonist | 0.026 0.012 DB11309 | DB11309 | |
| 0.018 | 0.605 | 0.521 | Platelet antagonist | 0.521 0.012 DBMET00488 | DBMET00488 | |
| 0.003 | 0.593 | 0.752 | Cholecystokinin B antagonist | 0.752 0.002 DB11309 | DB11309 | |
| 0.004 | 0.613 | 0.729 | Cholecystokinin antagonist | 0.729 0.002 DB11309 | DB11309 | |
| 0.013 | 0.627 | 0.064 | Trypsin inhibitor | 0.064 0.04 DB11309 | DB11309 | |
| 0.004 | 0.675 | 0.02 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.02 0.007 DBMET00488 | DBMET00488 | |
| 0.009 | 0.714 | 0.943 | Anticoagulant | 0.361 0.02 DBMET00488 0.943 0.003 DB11309 | DB11309 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |